1. Home
  2. TELA vs DLHC Comparison

TELA vs DLHC Comparison

Compare TELA & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELA
  • DLHC
  • Stock Information
  • Founded
  • TELA 2012
  • DLHC 1969
  • Country
  • TELA United States
  • DLHC United States
  • Employees
  • TELA N/A
  • DLHC N/A
  • Industry
  • TELA Medical/Dental Instruments
  • DLHC Business Services
  • Sector
  • TELA Health Care
  • DLHC Consumer Discretionary
  • Exchange
  • TELA Nasdaq
  • DLHC Nasdaq
  • Market Cap
  • TELA 104.0M
  • DLHC 112.9M
  • IPO Year
  • TELA 2019
  • DLHC N/A
  • Fundamental
  • Price
  • TELA $2.72
  • DLHC $5.37
  • Analyst Decision
  • TELA Strong Buy
  • DLHC
  • Analyst Count
  • TELA 4
  • DLHC 0
  • Target Price
  • TELA $9.25
  • DLHC N/A
  • AVG Volume (30 Days)
  • TELA 186.3K
  • DLHC 55.5K
  • Earning Date
  • TELA 03-20-2025
  • DLHC 02-05-2025
  • Dividend Yield
  • TELA N/A
  • DLHC N/A
  • EPS Growth
  • TELA N/A
  • DLHC 205.24
  • EPS
  • TELA N/A
  • DLHC 0.44
  • Revenue
  • TELA $68,649,000.00
  • DLHC $388,869,000.00
  • Revenue This Year
  • TELA $30.39
  • DLHC N/A
  • Revenue Next Year
  • TELA $25.51
  • DLHC N/A
  • P/E Ratio
  • TELA N/A
  • DLHC $12.24
  • Revenue Growth
  • TELA 29.34
  • DLHC N/A
  • 52 Week Low
  • TELA $2.30
  • DLHC $5.37
  • 52 Week High
  • TELA $7.18
  • DLHC $16.67
  • Technical
  • Relative Strength Index (RSI)
  • TELA 50.00
  • DLHC 18.22
  • Support Level
  • TELA $2.53
  • DLHC $6.15
  • Resistance Level
  • TELA $2.96
  • DLHC $6.18
  • Average True Range (ATR)
  • TELA 0.13
  • DLHC 0.29
  • MACD
  • TELA 0.02
  • DLHC -0.11
  • Stochastic Oscillator
  • TELA 44.19
  • DLHC 0.00

About TELA TELA Bio Inc.

TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.

About DLHC DLH Holdings Corp.

DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. It is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, and telehealth systems.

Share on Social Networks: